Located in the heart of Europe and led by Anne Katrin Hilbert, Managing Director, the Marburg laboratory maintains a staff of approximately 80 employees in a 22,600 square foot space. The facility operates under BSL-2 and BSL-3, with an additional 753 sq. ft. dedicated to the handling of genetically modified organisms.

With more than 20 years of demonstrated expertise in selecting, developing, and validating immunological assays in support of vaccine development in both Novartis and GSK global environments, we provide cutting-edge expertise on tailored functional and immuno-binding serological assays for vaccine licensures.

We operate under GCLP using fit-for-purpose quality systems with a track record of success in authority lab inspections.


Equipment and Techniques

The following is a list of equipment and techniques performed on our infectious disease platform within our laboratory operations at our Marburg location.

  • BioTek Instruments ELx808, ELx808IU
  • TECAN Infinite 200 Pro
  • BioTek 405 TS, EL x 405 RMF, 405 SRVS
  • Thermo Fisher Scientific KingFisher Duo Prime
  • Synbiosis ProtoCol3, ProtoCol4, ProtoCol5, ProtoCol6, ProtoCol7, ProtoCol8
  • TECAN Evo 75
  • TECAN Evo 200
  • TECAN Evo 100 Robotic Unit
  • Luminex Flexmap 3D
  • Scinomix Tube Labeler
  • Microtechnix Axiolab
  • Logos Biosystems Luna II
  • Microtechnix Scanlab II